These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 31494787)

  • 21. RET gene mutation analysis and long-term clinical outcomes of medullary thyroid cancer patients.
    Prabhu M; Shakya S; Ballal S; Ahmed Shamim S; Bal C
    Nucl Med Commun; 2020 Nov; 41(11):1136-1142. PubMed ID: 32796450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medullary Thyroid Carcinoma: Recent Advances Including MicroRNA Expression.
    Chu YH; Lloyd RV
    Endocr Pathol; 2016 Dec; 27(4):312-324. PubMed ID: 27539727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medullary thyroid carcinoma: pitfalls in diagnosis by fine needle aspiration cytology and relationship of cytomorphology to RET proto-oncogene mutations.
    Chang TC; Wu SL; Hsiao YL
    Acta Cytol; 2005; 49(5):477-82. PubMed ID: 16334022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome-wide copy number analysis in a family with p.G533C RET mutation and medullary thyroid carcinoma identified regions potentially associated with a higher predisposition to lymph node metastasis.
    Araujo AN; Moraes L; França MI; Hakonarson H; Li J; Pellegrino R; Maciel RM; Cerutti JM
    J Clin Endocrinol Metab; 2014 Jun; 99(6):E1104-12. PubMed ID: 24601688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synchronous metastatic medullary and papillary thyroid carcinomas in a patient with germline RET mutation: case report, molecular analysis, and implications for pathogenesis.
    Griffith C; Zhang S; Mukhopadhyay S
    Endocr Pathol; 2010 Jun; 21(2):115-9. PubMed ID: 20369307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sporadic minute medullary thyroid carcinoma with a double RET mutation: A case report.
    Yamamoto H; Ishii J; Chiba T; Nakazato Y; Hirano K; Kamma H
    Pathol Int; 2017 Nov; 67(11):580-584. PubMed ID: 28952196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [
    Wang Y; Du LL; Hou SH; Han CZ; Zhao XW; Wang WG; Xu XQ; Jing JX
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Nov; 51(11):873-876. PubMed ID: 27938622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative Clinical and Sonographic Predictors for Lateral Cervical Lymph Node Metastases in Sporadic Medullary Thyroid Carcinoma.
    Oh HS; Kwon H; Song E; Jeon MJ; Song DE; Kim TY; Lee JH; Hong SJ; Kim WB; Shong YK; Baek JH; Kim WG
    Thyroid; 2018 Mar; 28(3):362-368. PubMed ID: 29350102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of early screening and prophylactic thyroidectomy in asymptomatic nonindex RET germline carriers.
    Ukkat J; Lorenz K; Hinze R; Thomusch O; Dralle H
    World J Surg; 2001 Jun; 25(6):713-7. PubMed ID: 11376404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unilateral surgery supported by germline RET oncogene mutation analysis in patients with sporadic medullary thyroid carcinoma.
    Miyauchi A; Matsuzuka F; Hirai K; Yokozawa T; Kobayashi K; Kuma S; Kuma K; Futami H; Yamaguchi K
    World J Surg; 2000 Nov; 24(11):1367-72. PubMed ID: 11038208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.
    Frank-Raue K; Raue F
    Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critically evaluated key points on hereditary medullary thyroid carcinoma.
    Zhang D; Liang N; Sun H; Frattini F; Sui C; Yang M; Wang H; Dionigi G
    Front Endocrinol (Lausanne); 2024; 15():1412942. PubMed ID: 38919477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcome of "prophylactic therapy" for familial medullary thyroid cancer.
    Schellhaas E; König C; Frank-Raue K; Buhr HJ; Hotz HG
    Surgery; 2009 Nov; 146(5):906-12. PubMed ID: 19744457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cohort study on 10-year survival of sporadic medullary thyroid carcinoma with somatic RET mutation.
    Chuang LL; Hwang DY; Tsai KB; Chan HM; Chiang FY; Hsiao PJ
    Kaohsiung J Med Sci; 2016 Nov; 32(11):545-551. PubMed ID: 27847096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for cervical lymph node metastasis in the central or lateral cervical region in medullary thyroid carcinoma: a systematic review and meta-analysis.
    Lin X; Huo J; Su H; Zhu C; Xu Y; Zhang F
    Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):547-561. PubMed ID: 37801162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measuring discrepancies between simple medullary and synchronous medullary/papillary thyroid carcinomas: a comparative cross-sectional study.
    Zhang D; Yang M; Frattini F; Cestari A; Li K; Wang H; Chi H; Sui C; Bai K; Lan D; Dionigi G; Sun H
    Front Endocrinol (Lausanne); 2023; 14():1301200. PubMed ID: 38317715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.
    Elisei R; Bottici V; Cappagli V; Ramone T; Tacito A; Ciampi R; Romei C
    Ann Endocrinol (Paris); 2019 Jun; 80(3):187-190. PubMed ID: 31053251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Homozygous RET K666N Genotype With an MEN2A Phenotype.
    Jaber T; Hyde SM; Cote GJ; Grubbs EG; Giles WH; Stevens CA; Dadu R
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1269-1272. PubMed ID: 29408964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medullary thyroid carcinoma.
    Pacini F; Castagna MG; Cipri C; Schlumberger M
    Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):475-85. PubMed ID: 20627492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of risk factors for cervical lymph node metastases in patients with sporadic medullary thyroid carcinoma.
    Fan W; Xiao C; Wu F
    J Int Med Res; 2018 May; 46(5):1982-1989. PubMed ID: 29569965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.